Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study

scientific article

Are depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/HEAD.12534
P698PubMed publication ID25913219

P50authorAlberto RaggiQ37830338
Licia GrazziQ42702480
Domenico D'AmicoQ51846705
Matilde LeonardiQ56936660
Silvia SchiavolinQ57059900
Ambra Mara GiovannettiQ59661034
Gennaro BussoneQ78768461
Marcella CuroneQ114384573
Susanna UsaiQ114384574
P2093author name stringPaola Di Fiore
P2860cites workIncidence and predictors for chronicity of headache in patients with episodic migraineQ28249010
Self-efficacy: toward a unifying theory of behavioral changeQ28267991
Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based studyQ28294827
Social support and patient adherence to medical treatment: a meta-analysisQ34304004
Chronic headache and potentially modifiable risk factors: screening and behavioral management of sleep disordersQ34734317
Impaired functioning and quality of life in severe migraine: the role of catastrophizing and associated symptomsQ36248681
Social support and health: a review of physiological processes potentially underlying links to disease outcomesQ36499059
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patientsQ36878256
Tracing transformation: chronic migraine classification, progression, and epidemiologyQ37384074
Chronic migraine: epidemiology and disease burdenQ37808388
Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review.Q37861402
Disability in chronic daily headache: state of the art and future directionsQ37870786
Psychiatric comorbidities of episodic and chronic migraineQ38058242
Chronic migraine with medication overuse: association between disability and quality of life measures, and impact of disease on patients' livesQ39092504
Is β endorphin related to migraine headache and its relief?Q39234541
Migraine chronificationQ39792797
A 3-month analysis of disability, quality of life, and disease course in patients with migraineQ43688441
The role of tyrosine metabolism in the pathogenesis of chronic migraine.Q44071118
HIT-6 and MIDAS as measures of headache disability in a headache referral populationQ44243992
A 14-month study of change in disability and mood state in patients with chronic migraine associated to medication overuse.Q45004221
Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuseQ45376934
Family history for chronic headache and drug overuse as a risk factor for headache chronificationQ46097260
Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in TaiwanQ48344053
Interaction between anxiety, depression, quality of life and clinical parameters in chronic tension-type headache.Q50800376
The GRIM2005 study of migraine consultation in France I. Determinants of consultation for migraine headache in France.Q50886992
Social support and self-efficacy in patients with Myasthenia Gravis: a common pathway towards positive health outcomes.Q51601628
The GRIM2005 study of migraine consultation in France. III: Psychological features of subjects with migraine.Q51853652
World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation.Q51872611
Self-efficacy and social support as mediators in the relation between disease severity and quality of life in patients with epilepsy.Q52224599
Quality of life differs among headache diagnoses: analysis of SF-36 survey in 901 headache patients.Q53500187
Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centresQ56989664
Is General Self-Efficacy a Universal Construct?1Q57603184
P433issue5
P921main subjectdisabilityQ12131
migraineQ133823
P304page(s)636-645
P577publication date2015-04-23
P1433published inHeadacheQ5689497
P1476titleAre depressive symptomatology, self-efficacy, and perceived social support related to disability and quality of life in patients with chronic migraine associated to medication overuse? Data from a cross-sectional study
P478volume55

Reverse relations

cites work (P2860)
Q93017096A Prospective Observational Cohort Study on Pharmacological Habitus, Headache-Related Disability and Psychological Profile in Patients with Chronic Migraine Undergoing OnabotulinumtoxinA Prophylactic Treatment
Q47880975Clinical and psychosocial features of frequent relapsers (FR) among patients with chronic migraine and medication overuse
Q99578735Effects of Perceived Social Support, Depression and Anxiety Levels on Migraine
Q35930465Factors Related to Social Support in Neurological and Mental Disorders
Q96649196Humanistic and economic burden of depression and anxiety among adults with migraine: A systematic review
Q36624796Impact of depression and anxiety on burden and management of episodic and chronic headaches - a cross-sectional multicentre study in eight Austrian headache centres
Q37624770Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up
Q39175652Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study
Q39002028World Health Organization disability assessment schedule 2.0: An international systematic review

Search more.